Publications by authors named "Iain Cockburn"

Claim this Profile
E
Eye disorders reported with the use of mefloquine (Lariam(®)) chemoprophylaxis--A drug safety database analysis.
Miriam Adamcova, Martin T Schaerer, Isabella Bercaru, Iain Cockburn, Hans-Georg Rhein

Travel Med Infect Dis· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patents and the Global Diffusion of New Drugs.
Iain M Cockburn, Jean O Lanjouw, Mark Schankerman

Am Econ Rev· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The importance of patents to innovation: updated cross-industry comparisons with biopharmaceuticals.
Iain Cockburn, Genia Long

Expert Opin Ther Pat· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Economics of Reproducibility in Preclinical Research.
Leonard P Freedman, Iain M Cockburn, Timothy S Simcoe

PLoS Biol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The hidden cost of low prices: limited access to new drugs in India.
Ernst R Berndt, Iain M Cockburn

Health Aff (Millwood)· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bridging the gap: improving clinical development and the regulatory pathways for health products for neglected diseases.
Thomas J Bollyky, Iain M Cockburn, Ernst Berndt

Clin Trials· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The market for follow-on biologics: how will it evolve?
Henry Grabowski, Iain Cockburn, Genia Long

Health Aff (Millwood)· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of incremental innovation in biopharmaceuticals: drug utilisation in original and supplemental indications.
Ernst R Berndt, Iain M Cockburn, Karen A Grépin

Pharmacoeconomics· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The changing structure of the pharmaceutical industry.
Iain M Cockburn

Health Aff (Millwood)· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brave new industry, that has such patents in it! Reflections on the economic consequences of patenting DNA.
Iain M Cockburn

Adv Genet· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of clinical trial results on national trends in alpha-blocker prescribing, 1996-2002.
Randall S Stafford, Curt D Furberg, Stan N Finkelstein, Iain M Cockburn, Tseday Alehegn

JAMA· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A statistical analysis of the magnitude and composition of drug promotion in the United States in 1998.
Jun Ma, Randall S Stafford, Iain M Cockburn, Stan N Finkelstein

Clin Ther· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
National trends in asthma visits and asthma pharmacotherapy, 1978-2002.
Randall S Stafford, Jun Ma, Stan N Finkelstein, Kenan Haver, Iain Cockburn

J Allergy Clin Immunol· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis